The search for effective Alzheimer’s treatments is emerging as a promising market, capturing the attention of major ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Eli Lilly and Company’s LLY shares declined 13.5% in the past three months. Though demand for its popular tirzepatide drugs, ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 494.50% and ...

It leaves an image of Europe as a corporate has-been. Are the continent’s companies really that bad? Here are some counterpoints: America’s S&P 500 is in the midst of an artificial intelligence-led ...

The fund benefits from Baillie Gifford’s bold attitude but a portfolio shake-up has made it much more appealing to investors ...

Protean Small Cap beat its benchmark in December. It returned 0.3%, while the index retracted by -0.1%. Click here to read ...

These UK-based exchange-traded funds (ETFs) could help investors get 2025 off to a bang! Our writer Royston Wild explains why ...

With new treatments in neurology, and more in development in cardiology and autoimmune diseases, precision medicine is moving ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Novo Nordisk (NYSE: NVO) and AstraZeneca (NASDAQ: AZN) are among the largest companies in the pharmaceutical industry. Both ...